Through a fecal microbial transplantation assay, bacteria derived from the intestine and tumor of long-term survivors were shown to significantly activate IFN+CD8+ T cells and reduce tumor volume in a CD8+ T-cell manner (Fig. 8A). The gene discussed is CD8A; the disease is neoplasm.